![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
HE Shannon and BD Sawyer
Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana.
The excitatory amino acids L-glutamate and N-methyl-D-aspartate (NMDA) produced contractions of the myenteric plexus-longitudinal muscle preparation of the guinea pig ileum over the concentration range of 3 X 10(-6) to 10(-3) M. The contractile response to L-glutamate and NMDA, but not carbamyl choline, was blocked noncompetitively by 0.6 mM Mg++. In the absence of Mg++, concentration-dependent increases in contractile force also were produced by, in order of potency, L- aspartate, L-homocysteate and D-glutamate, but not by quisqualate, kainate or quinolinate. L-Glutamate was competitively antagonized by the selective NMDA receptor antagonists D-2-amino-5-phosphonovalerate and 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid (3 X 10(-6)-3 X 10(-5) M), as well as by the nonselective excitatory amino acid antagonist gamma-D-glutamylglycine (3 X 10(-4) M). Glutamic acid diethyl ester (3 X 10(-4) M) noncompetitively antagonized L-glutamate. L-Glutamate was not blocked by gamma-D-glutamylaminomethyl sulphonate (3 X 10(-4) M), an antagonist which preferentially antagonizes kainate and quisqualate. In addition, the phencyclidine-like drugs etoxadrol (10(-7)-10(-5) M), dextromethorphan (10(-6)-10(-5) M) and 5-methyl- 10,11-dihydroxy-5H-dibenzo(a,d)cyclohepten-5,10-imine (10(-9)-10(-7) M) noncompetitively antagonized L-glutamate. The (+) isomer of 5-methyl- 10, 11-dihydroxy-5H-dibenzo(a,d)cyclohepten-5,10-imine was approximately 10-fold more potent than the (-) isomer in antagonizing L- glutamate. The present results demonstrate that receptors for the excitatory amino acid L-glutamate are present in the guinea pig myenteric plexus and are of the NMDA subtype.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
|
|
 |
|
  A. Kohjitani, M. Funahashi, T. Miyawaki, M. Hanazaki, R. Matsuo, and M. Shimada Peripheral N-Methyl-d-Aspartate Receptors Modulate Nonadrenergic Noncholinergic Lower Esophageal Sphincter Relaxation in Rabbits Anesth. Analg., December 1, 2005; 101(6): 1681 - 1688. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. J. Chang, B. C. Yoo, S.-B. Lim, S.-Y. Jeong, W. H. Kim, and J.-G. Park Metabotropic Glutamate Receptor 4 Expression in Colorectal Carcinoma and Its Prognostic Significance Clin. Cancer Res., May 1, 2005; 11(9): 3288 - 3295. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. S. Gill and O. M. Pulido Review Article: Glutamate Receptors in Peripheral Tissues: Current Knowledge, Future Research, and Implications for Toxicology Toxicol Pathol, February 1, 2001; 29(2): 208 - 223. [Abstract] [PDF]
|
|
|
|
 |
|
 N. M. PEET, P. S. GRABOWSKI, I. LAKETIC-LJUBOJEVIC, and T. M. SKERRY The glutamate receptor antagonist MK801 modulates bone resorption in vitro by a mechanism predominantly involving osteoclast differentiation FASEB J, December 1, 1999; 13(15): 2179 - 2185. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. G. Genever, D. J.P. Wilkinson, A. J. Patton, N. M. Peet, Y. Hong, A. Mathur, J. D. Erusalimsky, and T. M. Skerry Expression of a Functional N-Methyl-D-Aspartate-Type Glutamate Receptor by Bone Marrow Megakaryocytes Blood, May 1, 1999; 93(9): 2876 - 2883. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. Kirchgessner, M.-T. Liu, and F. Alcantara Excitotoxicity in the Enteric Nervous System J. Neurosci., November 15, 1997; 17(22): 8804 - 8816. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-T. Liu, J. D. Rothstein, M. D. Gershon, and A. L. Kirchgessner Glutamatergic Enteric Neurons J. Neurosci., June 15, 1997; 17(12): 4764 - 4784. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. E. Shannon, M. J. Sheardown, F. P. Bymaster, D. O. Calligaro, N. W. Delapp, J. Gidda, C. H. Mitch, B. D. Sawyer, P. W. Stengel, J. S. Ward, et al. Pharmacology of Butylthio[2.2.2] (LY297802/NNC11-1053): A Novel Analgesic with Mixed Muscarinic Receptor Agonist and Antagonist Activity J. Pharmacol. Exp. Ther., May 1, 1997; 281(2): 884 - 894. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
